Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,132.40
(
0.00%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.71
(
-0.94%
)
Bitcoin
74,017.17
(
0.10%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: zipjet post# 107118

Sunday, 10/24/2010 10:16:50 PM

Sunday, October 24, 2010 10:16:50 PM

Post# of 257253
Well my reason for rejecting "never" is not based on the science as much as on the economics.

Teva can see a $250m/yr product if they get approval. That means it would be worthwhile for them to spend $500m to get it approved. I have to believe that given Teva's overall resources, $500m and the FDA roadmap can achieve approval.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now